logo

For the Inventor, By the Inventor

Misato, Japan

Masanori Inamasu

This inventor holds 11 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1980-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanori Inamasu. Retrieved from https://idiyas.com/inventor/masanori-inamasu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 254(Granted Patents)


Company Filing History:

goldMedal11 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1980-1998

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5830873 - Propiophenone derivative and a process for preparing the same (1998-11-03),
2. 5731292 - Dihydrochalcone derivatives which are hypoglycemic agents (1998-03-24),
3. 5639789 - Butadiene derivatives and process for using the same (1997-06-17),
4. 5514815 - Succinimide derivatives and process for preparing the same (1996-05-07),
5. 5424406 - Dihydrochalcone derivatives which are hypoglycemic agents (1995-06-13),
6. 4948900 - Benzoxazole derivatives (1990-08-14),
7. 4897393 - Benzoxazole derivatives (1990-01-30),
8. 4824833 - Benzoxazine derivatives (1989-04-25),
9. 4490392 - Benzylalcohol derivative and process for preparing (1984-12-25),
10. 4276304 - Novel benzylalcohol derivative and process for preparing the same (1981-06-30),
11. 4218479 - Novel benzylalcohols and pharmaceutical compositions and use thereof (1980-08-19),

Title: Masanori Inamasu: Innovator in Hypoglycemic Agents

Introduction

Masanori Inamasu is a prominent inventor based in Misato, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypoglycemic agents. With a total of 11 patents to his name, Inamasu's work has the potential to impact the treatment of diabetes significantly.

Latest Patents

Among his latest patents is a propiophenone derivative, which is designed to have excellent hypoglycemic activity. This compound is useful in the prophylaxis or treatment of diabetes. Another notable patent involves dihydrochalcone derivatives, which serve as hypoglycemic agents. These compounds are formulated to be administered to patients with diabetes, showcasing Inamasu's commitment to advancing medical science.

Career Highlights

Masanori Inamasu is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to improve diabetes management through novel chemical compounds.

Collaborations

Inamasu has collaborated with notable coworkers, including Kenji Tsujihara and Mitsuya Hongu. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Masanori Inamasu's contributions to the development of hypoglycemic agents highlight his role as a key innovator in the pharmaceutical industry. His patents reflect a dedication to improving health outcomes for individuals with diabetes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…